Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alexandre Hirayama"'
Autor:
Emily Liang, Alexandre Hirayama, Erik Kimble, Andrew Portuguese, Aya Albittar, Aude Chapuis, Mazyar Shadman, Brian Till, Ryan Cassaday, Filippo Milano, Hans-Peter Kiem, Camesron Turtle, David Maloney, Jordan Gauthier
Publikováno v:
HemaSphere, Vol 7, p e472395b (2023)
Externí odkaz:
https://doaj.org/article/bbcc7f0028174aafbdea512348cb5efc
Autor:
Mazyar Shadman, Cecilia Yeung, Mary W Redman, Sang Yun Lee, Dong Hoon Lee, Susan Ra, David H Qian, Bruce Dezube, Aude Chapuis, Damian Green, Andrew Cowan, Ryan Cassaday, Hans-Peter Kiem, Houston E Warren, Filippo Milano, Jordan Gauthier, Alexandre Hirayama, Mary Kwok, Chaitra Ujjani, David Maloney, Ajay Gopal, Brian Till
Publikováno v:
HemaSphere, Vol 7, p e68877ca (2023)
Externí odkaz:
https://doaj.org/article/d8bb754945964d2fac1aef76598bd45e
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/8d6ed7223a8747018a5fe1b3cac815f7
Autor:
Damian Green, David Maloney, David Woolston, Alexandre Hirayama, Cameron Turtle, Cecilia Yeung, KiBeom Kwon
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/cfc1724f506f4bdea93828e4129487e7
Autor:
Shalini Pullarkat, Jocelyn Wright, David Woolston, Erik Kimble, Bo Lee, Alexandre Hirayama, Aude Chapuis, Denise Buenrostro, Graeme Black, Marie Bleakley, Brandon Seaton, Jennifer Specht, Cameron Turtle, Cecilia Yeung
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f7c9e3dfeab6003b96569c5bbe7f0ba
https://doi.org/10.1136/jitc-2022-sitc2022.0093
https://doi.org/10.1136/jitc-2022-sitc2022.0093
Autor:
Tony Chour, Alexandre Hirayama, Ye Zheng, Alyssa Sheih, Summer Zhuang, Ashley Wilson, Vicky Wu, Raphael Gottardo, Cameron Turtle, Rebecca Gardner, Evan Newell
Publikováno v:
Cancer Research. 82:3910-3910
CD19 CAR T cell therapy has emerged as a promising therapy in the treatment of B cell malignancies, such as B cell acute lymphoblastic leukemia (B-ALL). However, questions remain regarding the heterogeneity of the CAR T cell infusion products that le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2321a39c75a50697dd580191c50b5ad6
https://doi.org/10.1158/1538-7445.am2022-3910
https://doi.org/10.1158/1538-7445.am2022-3910